Health: Public Affairs & Public Relations Support
Brevia Health provides straightforward public affairs and communications advice and support to organisations operating in the highly regulated UK healthcare sector. The consultancy brings together experts who have held senior roles in NICE, MHRA, Government Health teams, Opposition Health teams and across industry. We use this rounded perspective to bring new thinking and well-developed proposals across a wide range of policy areas.
As the UK emerges from the far-reaching consequences of COVID-19 and BREXIT, it is clear that the healthcare system has changed, and leaders are open to new approaches. Never has there been a better time for organisations to make practical, thought-through proposals which show broad-based benefits.
The much anticipated publication of the NHS Commercial Framework for New Medicines in 2021 represents a significant milestone for the pharmaceutical industry. It outlines the purpose and principles on which NHS commercial medicines activity will be based, defines the roles and responsibilities of those involved in commercial medicines activity and details how pharmaceutical companies can engage with the NHS.
Brevia Health supports global multi-nationals, innovative start-ups, providers, and charities. Our experience includes supporting companies to win IT contracts with the NHS through to gaining approval for medicines with NICE. We have also worked in areas such as in vitro diagnostics, medical devices, and genomics, as well as delivering programmes involving policy and stakeholder research, political and media monitoring, stakeholder engagement, event management, media relations, Party Conferences, and Select Committee training.
For more information about Brevia Health, our client experience and team of health consultants, please visit our dedicated website: www.breviahealth.com.
To organise a discussion with Brevia Health on how we can help you and your organisation, please get in touch via the link here. You can also contact the Brevia Health Team on 020 7091 1655 or email contact@breviahealth.com
OUR SENIOR COUNSEL INCLUDES:
CLIENT EXPERIENCE
TESTIMONIALS
NEWS
DIP-ping into the DESNZ budget
The outgoing Prime Minister has confirmed that funding the Defence Investment Plan (DIP) will require capital projects in roads and energy to be scrapped. On top of the 1% reduction in capital budgets that all Departments must find to fund the DIP, DESNZ will be tasked with finding a further £2bn savings over four years. For DESNZ this means a £100m capital budget reduction this calendar year, £600m in 2027/28, £700m in 2028/29, and £600m in 2029/30. This article explores where these savings might come and potential impact on DESNZ commitments.
Greater Manchester Mayoral Election 2026: Everything You Need to Know
Discover the candidates in the 2026 Greater Manchester mayoral election, and what the result could mean for businesses, investment and policy.
What a Burnham Government could mean for the energy sector
Andy Burnham’s first major speech since announcing his leadership candidacy reinforced his commitment to devolution, greater public control and long-term infrastructure investment. In this article Brevia Energy examines what his agenda, and the thinking underpinning “Manchesterism”, could mean for the energy sector.
WORK WITH US
A track record in delivering results
Brevia Health delivers tailored support to businesses and charities operating in the health sector. Our three-step process offers a straightforward approach to delivering crucial intelligence, strategic advice and stakeholder engagement.